Clin2
NCT07522970Likely a fitRecruiting

Safety and Tolerability Study of LG-0317 in Healthy Adults

Healthy Volunteers

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Age 18–45 years old and in generally good health with no major medical conditions
  • Weigh at least 50 kg (about 110 lbs) and have a normal body mass index between 18–32
  • Not pregnant, not breastfeeding, and willing to use contraception during the study and for 3 months after
  • No history of allergies to drugs, mental health conditions, or substance use
  • Not a regular smoker (fewer than 5 cigarettes per day in the past 3 months)
  • Not taken any prescription drugs, over-the-counter medicines, or supplements in the past 2 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07797855Recruiting· Phase 1
Testing a new medicine's safety in healthy people

This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Groningen
NCT06904807Recruiting· Phase 1
Safety study of LIFE-001 in healthy volunteers

This trial tests a new drug called LIFE-001 in healthy volunteers to check its safety and how the body handles it. It is for people without significant health issues.

Bayswater, Victoria
NCT07765706Recruiting· Phase 1
Testing an investigational medicine in healthy volunteers

This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.

Salt Lake City, Utah
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT06867393Recruiting· Phase 1
Safety study of HL-003 in healthy volunteers

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Suzhou, Jiangsu

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.